Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Radmila Ajduković

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and CHOP

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2010English

FOXP1 Expression in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Pathology International
MedicineForensic MedicinePathology
2009English

Related publications

Multiplex Polymerase Chain Reaction-Based Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Treated With R-Chop

British Journal of Haematology
Hematology
2016English

Prognostic Significance of Ki67 and Its Correlation With Mitotic Index in Dogs With Diffuse Large B-Cell Lymphoma Treated With 19-Week CHOP-based Protocol

Journal of Veterinary Diagnostic Investigation
Veterinary
2017English

Prognostic Significance of Serum Immunoglobulin Paraprotein in Patients With Diffuse Large B Cell Lymphoma

British Journal of Haematology
Hematology
2017English

PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B-Cell LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB-CHOP (RCHOP) ± RADIOTHERAPY (RT)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Real-World Prognostic Impact of Bcl2 and Myc Expression and Translocation Among Diffuse Large B-Cell Lymphoma Patients Treated With First-Line R-Chop

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Tumor Necrosis as a Prognostic Factor of Diffuse Large B-Cell Lymphoma Treated With R-Chop Therapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Diffuse Large B-Cell Lymphoma Presenting With Gastrocolic Fistula and Successfully Treated With R-Chop Chemotherapy

Tenri Medical Bulletin
2018English

MELK Serves as a Potent Independent Biomarker to Predict Survival of Diffuse Large B-Cell Lymphoma Patients Treated With Rituximab-Chop Regimen

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy